Denmark-based feed company BioMar is doubling the capacity of its facility in Wuxi, China, via a joint partnership with Tongwei.
BioMar said the company is working on the expansion throughout 2026, which will expand the facility to encompass two lines rather than the sole existing one. The move will expand capacity, allow the company to begin producing new specialty products, and serve new customer segments, the company said.
“In recent years, we have developed a substantial business presence in China, where we collaborate with customers to introduce innovative feed solutions grounded in BioMar’s research and global experience with high-value species and sustainable aquaculture nutrition,” BioMar CEO Carlos Diaz said. “Our goal is to elevate this success by expanding the production capacity in Wuxi with 50,000 metric tons [MT] while integrating advanced technological capabilities into our production facility.”
BioMar said it currently has a total capacity in China of 200,000 MT, via its Wuxi facility and a facility operated together with its joint venture partner Tongwei in Zhuhai. It said those facilities are currently at capacity and are limiting the growth opportunities of BioMar in China.
BioMar entered the Chinese market in 2016, and in 2017, it reported it was planning to turn its focus to the Chinese feed market. Soon after that, it began constructing the facility in Wuxi – its second facility in China – which ended up facing a series of delays which included challenges with its contractor.
The company ultimately got its facility up and running in the first quarter of 2020 and has since been capable of producing 50,000 MT of products a year. The new expansion will help double that and is expected to be commissioned in Q1 2027.
BioMar’s expansion of the facility will further its expansion ambitions in China and is a part of its overall growth strategy, the company said.
“We have built a solid model expanding the business, being ambitious in our growth aspirations while ensuring that each courageous step into new markets is being nurtured and integrated into the BioMar business model,” Diaz said. “I see this clearly reflected in our books, where investments have historically been followed by growth in volumes and earnings, creating a strong global business for BioMar.”
BioMar recently reported flat revenue and earnings in FY 2025, despite what it described as challenges in Q3.
